MONO-, DI- UND TRIALLYLIERTES 5-(HYDROXYMETHYL) URACIL. = HYDROXYMETHYL-5 URACILE MONO-, DI- ET TRIALLYLEESCHENFELDER V; BROSSMER R.1977; ANN. (JUSTUS LIEBIGS) CHEM.; DTSCH.; DA. 1977; NO 11-12; PP. 1969-1975; ABS. ANGL.; BIBL. 12 REF.Article

SYNTHESIS OF ANOMERIC ETHYL KETOSIDES OF 5-N-ACETYL-D-NEURAMINIC ACIDESCHENFELDER V; BROSSMER R.1979; Z. (HOPPE-SEYLER'S) PHYSIOL. CHEM.; DEU; DA. 1979; VOL. 360; NO 9; PP. 1253-1256; ABS. GER; BIBL. 10 REF.Article

A NEW APPROACH TO THE SYNTHESIS OF 5-N-ACETYL-D-NEURAMINIC ACID ALPHA -KETOSIDESESCHENFELDER V; BROSSMER R.1980; CARBOHYD. RES.; NLD; DA. 1980; VOL. 78; NO 1; PP. 190-194; BIBL. 9 REF.Article

HISTOCHEMISCHER NACHWEIS DER NEURAMINIDASE = MISE EN EVIDENCE HISTOCHIMIQUE DE LA NEURAMINIDASEGOSSRAU R; ESCHENFELDER V.1977; ANAT. ANZ.; DDR; DA. 1977; VOL. 144; NO SUPPL.; PP. 391-393; ABS. ENG; BIBL. 5 REF.Article

SYNTHESE VON 5-(BETA -D-GLUCOPYRANOSY LOXYMETHYL) URACIL UND 1,3-DIMETHYL-5-(BETA -D-GLUCOPYRANOSYLOXYMETHYL) URACIL = SYNTHESE DE (BETA -D-GLUCOPYRANNOSYLOXYMETHYL)-5 URACILE ET DE DIMETHYL-1,3 (BETA -D-GLYCOPYRANNOSYLOXYMETHYL)-5 URACILEBROSSMER R; ESCHENFELDER V.1974; ANN. (JUSTUS LIEBIGS) CHEM.; DTSCH.; DA. 1974; NO 6; PP. 967-974; ABS. ANGL.; BIBL. 15 REF.Article

SYNTHESE VON 5-(ALPHA -D-GLUCOPYRANOSYLOXYMETHYL)-3-(BETA -D-RIBOFURANOSYL) URACIL UND 3-(2-DESOXY-BETA -D-RIBOFURANOSYL)-5-(ALPHA -D-GLUCOPYRANOSYLOXYMETHYL) URACIL ALS ANALOGA EINES DNA-BAUSTEINS = SYNTHESE D'(ALPHA -D-GLUCOPYRANNOSYLOXYMETHYL)-5 (BETA -D-RIBOFURANNOSYL)-3 URACILE ET DE (DESOXY-2 BETA -D-RIBOFURANNOSYL)-3 (ALPHA -D-GLUCOPYRANNOSYL-OXYMETHYL)-5 URACILE EN TANT QUE SEQUENCE DE L'ADNBROSSMER R; ESCHENFELDER V.1974; ANN. (JUSTUS LIEBIGS) CHEM.; DTSCH.; DA. 1974; NO 6; PP. 975-981; ABS. ANGL.; BIBL. 9 REF.Article

NUCLEOSID-ANALOGA DES 5-HYDROXYMETHYL-URACILS = NUCLEOSIDES ANALOGUES DE L'HYDROXYMETHYL-5 URACILEBROSSMER R; ESCHENFELDER V.1972; ANN. (JUSTUS LIEBIGS) CHEM.; DTSCH.; DA. 1972; VOL. 762; PP. 160-166; ABS. ANGL.; BIBL. 11 REF.Serial Issue

5-BROM-3-INDOLYL-ALPHA -KETOSIDE OF 5-N-ACETYL-D-NEURAMINIC ACID A NEW SUBSTRATE FOR THE LIGHT AND ELECTRON MICROSCOPIC DEMONSTRATION OF MAMMALIAN NEURAMINIDASE.GOSSRAU R; ESCHENFELDER V; BROSSMER R et al.1977; HISTOCHEMISTRY; GERM.; DA. 1977; VOL. 53; NO 2; PP. 189-192; BIBL. 10 REF.Article

CIRCULAR DICHROISM STUDIES ON ALPHA - AND BETA -KETOSIDES OF 5-ACETAMIDO-3,5 DIDEOXY-D-GLYCERO-D-GALACTO-NONULOPYRANOSONIC ACID (N-ACETYLNEURAMINIC ACID) AND OF SOME OF ITS DERIVATIVES.KEILICH G; BROSSMER R; ESCHENFELDER V et al.1975; CARBOHYD. RES.; NETHERL.; DA. 1975; VOL. 40; NO 2; PP. 255-262; BIBL. 13 REF.Article

Synthesis of p-nitrophenyl 5-acetamido-3,5-dideoxy-α-D-glycero-D-galacto-2-nonulopyranosidonic acid, a chromogenic substrate for sialidasesESCHENFELDER, V; BROSSMER, R.Carbohydrate research. 1987, Vol 162, Num 2, pp 294-297, issn 0008-6215Article

Neutralization of the anticoagulant activity of low molecular weight heparin LU 47311 (Clivarin®) in man by protamine chlorideANDRASSY, K; ESCHENFELDER, V; WEBER, E et al.Thrombosis research. 1994, Vol 73, Num 2, pp 85-93, issn 0049-3848Article

Langzeit-Verlaufsbeobachtungen an Linsen von Diabetikern mittels Linear-Densitometrie von Scheimpflug-Photographien = Etude longitudinale des cristallins de diabétiques par la densitométrie linéaire des photographies Scheimpflug = Long-term follow-up of lenses of diabetics by means of linear densitometry of Scheimpflug photosOLBERT, D; HOCKWIN, O; BAUMGÄRTNER, A et al.Klinische Monatsblätter für Augenheilkunde. 1986, Vol 189, Num 5, pp 363-366, issn 0023-2165Conference Paper

Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty : A comparison between treatment with reviparin and unfractionated heparin/placebo (results of a substudy of the REDUCE trial)PREISACK, M. B; BONAN, R; MEISNER, C et al.European heart journal. 1998, Vol 19, Num 8, pp 1232-1238, issn 0195-668XArticle

Effect of recombinant hirudin (LU 52369) on reocclusion rates after thrombolysis in rabbitsRÜBSAMEN, K; ESCHENFELDER, V.Haemostasis. 1991, Vol 21, pp 93-98, issn 0301-0147, SUP1Conference Paper

Pharmacologic validation of the clinical effects of an optimized low-molecular-weight heparin : reviparinFAREED, J; JESKE, W; ESCHENFELDER, V et al.Seminars in thrombosis and hemostasis. 1995, Vol 21, Num 2, pp 212-227, issn 0094-6176Article

Effects of enzymatic blood defibrination in subcortical arteriosclerotic encephalopathyRINGELSTEIN, E. B; MAUCKNER, A; ESCHENFELDER, V et al.Journal of neurology, neurosurgery and psychiatry. 1988, Vol 51, Num 8, pp 1051-1057, issn 0022-3050Article

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty : Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)KARSCH, K. R; PREISACK, M. B; SHIU, M. F et al.Journal of the American College of Cardiology. 1996, Vol 28, Num 6, pp 1437-1443, issn 0735-1097Article

Niedermolekulares Heparin, Reviparin, nach PTCA : Ergebnisse einer randomisierten, doppelblinden, Standard-Heparin- und Plazebo-kontrollierten multizentrischen Studie (REDUCE-Studie) = Low molecular weight heparin, reviparin after PTCA : results of a randomized, double-blind, standard heparin and placebo controlled multicenteral study (REDUCE Trial)PREISACK, M. B; BAILDON, R; SUJATTA, M et al.Zeitschrift für Kardiologie (Print). 1997, Vol 86, Num 8, pp 581-591, issn 0300-5860Article